Pro-Pe adhesive tablet

Phase 2Active
0 watching 0 views this week Active
44
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Ulcer, Aphthous

Conditions

Ulcer, Aphthous

Trial Timeline

— → May 1, 2007

About Pro-Pe adhesive tablet

Pro-Pe adhesive tablet is a phase 2 stage product being developed by Advanced Medical Solutions Group for Ulcer, Aphthous. The current trial status is active. This product is registered under clinical trial identifier NCT00281723. Target conditions include Ulcer, Aphthous.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00281723Phase 2Active

Competing Products

20 competing products in Ulcer, Aphthous

See all competitors
ProductCompanyStageHype Score
CHF6467 activeComac MedicalPhase 1/2
33
Mirikizumab SC + Mirikizumab IV + Placebo SCEli LillyPhase 3
77
MirikizumabEli LillyPhase 2
52
Azathioprine + PlaceboCelltrionApproved
85
CT-P13 SC (Infliximab)CelltrionPhase 3
77
Afimkibart + PlaceboChugai PharmaceuticalPhase 3
77
TacrolimusAstellas PharmaPhase 3
77
tacrolimus + PlaceboAstellas PharmaPhase 3
77
E3810 + E3810 + TeprenoneEisaiPhase 2/3
65
Filgotinib MaleateEisaiApproved
85
AJM300 + PlaceboEisaiPhase 3
77
E0671 + rabeprazole sodium + E0671 placeboEisaiApproved
85
GSK3050002 + PlaceboEisaiPhase 1
33
Rabeprazole + RabeprazoleEisaiPhase 2/3
65
adalimumab + placeboEisaiPhase 3
77
E6007 + PlaceboEisaiPhase 2
52
ParietEisaiPre-clinical
23
KHK4083 + PlaceboKyowa KirinPhase 2
52
KHK4083 + PlaceboKyowa KirinPhase 1
33
Arm1 + Arm 2Zydus LifesciencesPhase 2
52

Other Products from Advanced Medical Solutions Group